BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

60 related articles for article (PubMed ID: 2443918)

  • 1. Expression of the c-myc proto-oncogene in prostatic tissue.
    Matusik RJ; Fleming WH; Hamel A; Westenbrink TG; Hrabarchuk B; MacDonald R; Ramsey E; Gartner JG; Pettigrew NM; Johnston B
    Prog Clin Biol Res; 1987; 239():91-112. PubMed ID: 2443918
    [No Abstract]   [Full Text] [Related]  

  • 2. Expression of the c-myc protooncogene in human prostatic carcinoma and benign prostatic hyperplasia.
    Fleming WH; Hamel A; MacDonald R; Ramsey E; Pettigrew NM; Johnston B; Dodd JG; Matusik RJ
    Cancer Res; 1986 Mar; 46(3):1535-8. PubMed ID: 2417706
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interferon-gamma and its functional receptors overexpression in benign prostatic hyperplasia and prostatic carcinoma: parallelism with c-myc and p53 expression.
    Royuela M; de Miguel MP; Ruiz A; Fraile B; Arenas MI; Romo E; Paniagua R
    Eur Cytokine Netw; 2000 Mar; 11(1):119-27. PubMed ID: 10705309
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Apoptosis-related gene expression in benign prostatic hyperplasia and prostate carcinoma.
    Iacopino F; Angelucci C; Lama G; Zelano G; La Torre G; D'Addessi A; Giovannini C; Bertaccini A; Macaluso MP; Martorana G; Sica G
    Anticancer Res; 2006; 26(3A):1849-54. PubMed ID: 16827116
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In situ expression of mRNA for proto-oncogenes in benign prostatic hyperplasia and in prostatic carcinoma.
    Funa K; Nordgren H; Nilsson S
    Scand J Urol Nephrol; 1991; 25(2):95-100. PubMed ID: 1714628
    [TBL] [Abstract][Full Text] [Related]  

  • 6. BCL-2 proto-oncogene expression in prostate cancer and its relationship to the prostatic neuroendocrine cell.
    Segal NH; Cohen RJ; Haffejee Z; Savage N
    Arch Pathol Lab Med; 1994 Jun; 118(6):616-8. PubMed ID: 8204007
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of the c-rel and c-myc proto-oncogenes in avian tissues.
    Moore BE; Bose HR
    Oncogene; 1989 Jul; 4(7):845-52. PubMed ID: 2666905
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Unopposed c-MYC expression in benign prostatic epithelium causes a cancer phenotype.
    Williams K; Fernandez S; Stien X; Ishii K; Love HD; Lau YF; Roberts RL; Hayward SW
    Prostate; 2005 Jun; 63(4):369-84. PubMed ID: 15937962
    [TBL] [Abstract][Full Text] [Related]  

  • 9. KAI1/CD82 gene expression in benign prostatic hyperplasia and late-stage prostate cancer in Chinese.
    Hu WL; Li YQ; He HX; Li QR; Tian Y; Lai RQ; Mei H
    Asian J Androl; 2000 Sep; 2(3):221-4. PubMed ID: 11225981
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Regulation of c-sis expression in tumors of the male reproductive tract.
    Smith RG; Nag A
    Prog Clin Biol Res; 1987; 239():113-22. PubMed ID: 3309952
    [No Abstract]   [Full Text] [Related]  

  • 11. Tissue and age specific expression of the myc proto-oncogene family throughout the life span of the C57BL/6J mouse strain.
    Semsei I; Ma SY; Cutler RG
    Oncogene; 1989 Apr; 4(4):465-71. PubMed ID: 2470008
    [TBL] [Abstract][Full Text] [Related]  

  • 12. c-met proto-oncogene expression in benign and malignant human prostate tissues.
    Pisters LL; Troncoso P; Zhau HE; Li W; von Eschenbach AC; Chung LW
    J Urol; 1995 Jul; 154(1):293-8. PubMed ID: 7539865
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of c-jun oncogene in hyperplastic and carcinomatous human prostate.
    Tiniakos DG; Mitropoulos D; Kyroudi-Voulgari A; Soura K; Kittas C
    Urology; 2006 Jan; 67(1):204-8. PubMed ID: 16413376
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Analysis of the methylation pattern of c-Ha-ras oncogene in human prostatic cancer.
    Menegazzi M; Scarpa A; Libonati M
    Ital J Biochem; 1988; 37(2):104-10. PubMed ID: 3042687
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reverse transcriptase-PCR analysis of apoptosis-regulating gene expression in human benign prostatic hyperplasia.
    Angelucci C; Iacopino F; Lama G; Zelano G; Gianesini G; Sica G; Bono AV
    Anticancer Res; 2005; 25(6B):3937-41. PubMed ID: 16309180
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Detection of c-myc oncogene amplification and chromosomal anomalies in metastatic prostatic carcinoma by fluorescence in situ hybridization.
    Jenkins RB; Qian J; Lieber MM; Bostwick DG
    Cancer Res; 1997 Feb; 57(3):524-31. PubMed ID: 9012485
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An unusual alteration in c-myc in tissue from a primary breast carcinoma.
    Varley JM; Wainwright AM; Brammar WJ
    Oncogene; 1987; 1(4):431-8. PubMed ID: 2838785
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Basic research in prostate cancer: molecular biology.
    Effert PJ; Strohmeyer TG
    Acta Urol Belg; 1994 Apr; 62(1):15-21. PubMed ID: 8197925
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Keratinocyte growth factor induces mammary and prostatic hyperplasia and mammary adenocarcinoma in transgenic mice.
    Kitsberg DI; Leder P
    Oncogene; 1996 Dec; 13(12):2507-15. PubMed ID: 9000125
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Elevated expression of c-myc proto-oncogene in scleroderma fibroblasts.
    Trojanowska M; Wu LT; LeRoy EC
    Oncogene; 1988 Oct; 3(4):477-81. PubMed ID: 3078955
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.